Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Gian Benedetto Melis, Manuela Neri, Bruno Piras, Anna Maria Paoletti, Silvia Ajossa, Monica Pilloni, Maria Francesca Marotto, Valentina Corda, Alessandra Saba, Elena Giancane & Valerio Mais. (2018) Vilaprisan for treating uterine fibroids. Expert Opinion on Investigational Drugs 27:5, pages 497-505.
Read now
Read now
Simone Ferrero, Valerio Gaetano Vellone & Fabio Barra. (2018) Pharmacokinetic drug evaluation of ulipristal acetate for the treatment of uterine fibroids. Expert Opinion on Drug Metabolism & Toxicology 14:1, pages 107-116.
Read now
Read now
Aymara Mas, Marta Tarazona, Joana Dasí Carrasco, Gloria Estaca, Ignacio Cristóbal & Javier Monleón. (2017) Updated approaches for management of uterine fibroids. International Journal of Women's Health 9, pages 607-617.
Read now
Read now
Andrea Wagenfeld, Philippa T.K. Saunders, Lucy Whitaker & Hilary O.D. Critchley. (2016) Selective progesterone receptor modulators (SPRMs): progesterone receptor action, mode of action on the endometrium and treatment options in gynecological therapies. Expert Opinion on Therapeutic Targets 20:9, pages 1045-1054.
Read now
Read now
Emanuela Tafi, Carolina Scala, Umberto Leone Roberti Maggiore, Nicolò Bizzarri, Massimo Candiani, Pier Luigi Venturini & Simone Ferrero. (2015) Drug safety evaluation of ulipristal acetate in the treatment of uterine fibroids. Expert Opinion on Drug Safety 14:6, pages 965-977.
Read now
Read now
Silvia Di Tommaso, Serafina Massari, Antonio Malvasi, Daniele Vergara, Michele Maffia, Marilena Greco & Andrea Tinelli. (2015) Selective genetic analysis of myoma pseudocapsule and potential biological impact on uterine fibroid medical therapy. Expert Opinion on Therapeutic Targets 19:1, pages 7-12.
Read now
Read now
Giuseppe Benagiano, Carlo Bastianelli, Manuela Farris & Ivo Brosens. (2014) Selective progesterone receptor modulators: an update. Expert Opinion on Pharmacotherapy 15:10, pages 1403-1415.
Read now
Read now
Friederike Hoellen, Achim Rody, Andrea Ros, Angela Bruns, Christoph Cirkel & Michael K. Bohlmann. (2014) Hybrid approach of retractor-based and conventional laparoscopy enabling minimally invasive hysterectomy in a morbidly obese patient: Case report and review of the literature. Minimally Invasive Therapy & Allied Technologies 23:3, pages 184-187.
Read now
Read now
Articles from other publishers (21)
Nainita Patel, Kamlesh Chaudhari, Dharmesh Patel & Jalormy Joshi. (2023) High-Intensity Focused Ultrasound Ablation of Uterine Fibroids: A Review. Cureus.
Crossref
Crossref
Jiajun Xia, Dengke Teng, Guoqing Sui, Qiang Luo, Yuanqiang Lin & Hui Wang. (2023) Effectiveness and Safety of Ultrasound-guided Percutaneous Microwave Ablation for a Single Uterine Fibroid Greater than 300 cm3. Journal of Minimally Invasive Gynecology 30:4, pages 290-299.
Crossref
Crossref
Tobias A. Plöger, Stefan Koep, Hans-Christian Militzer & Andreas H. Göller. (2020) Combined experimental and quantum mechanical elucidation of the synthetically accessible stereoisomers of Hydroxyestradienone (HED), the starting material for vilaprisan synthesis. Journal of Computer-Aided Molecular Design 35:4, pages 505-516.
Crossref
Crossref
Matthias D’Hondt, Frederick Verbeke, Pieter Wuytens, Andre Skirtach, Bart De Spiegeleer & Evelien Wynendaele. (2019) Hot-melt Preparation of a Non-biodegradable Peptide Implant: A Proof of Principle. Protein & Peptide Letters 26:9, pages 691-701.
Crossref
Crossref
Michael K. Bohlmann, Magdalena Bohlig, Friederike Hoellen, Christine M. Rimpl, Nicole Sänger, Maliha Sadick & Peter Hunold. (2019) Radiologisch-interventionelle Methoden der MyombehandlungRadiological interventions as methods of treatment for uterine fibroids. Der Gynäkologe 52:4, pages 264-272.
Crossref
Crossref
Minhee LeeTae Hee KimSe Jeong KimByung Chul Jee. (2019) Posterior reversible encephalopathy syndrome in a woman who used gonadotropin-releasing hormone agonists: a case report. Obstetrics & Gynecology Science 62:1, pages 69.
Crossref
Crossref
Onchee Yu, Delia Scholes, Renate Schulze-Rath, Jane Grafton, Kelly Hansen & Susan D. Reed. (2018) A US population-based study of uterine fibroid diagnosis incidence, trends, and prevalence: 2005 through 2014. American Journal of Obstetrics and Gynecology 219:6, pages 591.e1-591.e8.
Crossref
Crossref
Vikram Sinai Talaulikar. (2018) Medical therapy for fibroids: An overview. Best Practice & Research Clinical Obstetrics & Gynaecology 46, pages 48-56.
Crossref
Crossref
C Zhang, H Jacobson, ZE Ngobese & R Setzen. (2017) Efficacy and safety of ultrasound‐guided high intensity focused ultrasound ablation of symptomatic uterine fibroids in Black women: a preliminary study. BJOG: An International Journal of Obstetrics & Gynaecology 124:S3, pages 12-17.
Crossref
Crossref
Thorben Ahrens, Achim Rody & Friederike Hoellen. 2017. Minimalinvasive Viszeralchirurgie. Minimalinvasive Viszeralchirurgie
35
43
.
Natalia V Aganezova. (2016) Modern possibilities of drug treatment of uterine fibroids. Journal of obstetrics and women's diseases 65:3, pages 79-83.
Crossref
Crossref
Zhang Bing-song, Zhang Jing, Han Zhi-yu, Xu Chang-tao, Xu Rui-fang, Li Xiu-mei & Liu Hui. (2016) Unplanned pregnancy after ultrasound-guided percutaneous microwave ablation of uterine fibroids: A follow-up study. Scientific Reports 6:1.
Crossref
Crossref
Christina Selgrad & Olaf Ortmann. (2016) Selektive ProgesteronrezeptormodulatorenSelective progesterone receptor modulators. Gynäkologische Endokrinologie 14:1, pages 44-48.
Crossref
Crossref
F. Hoellen, A. Hornemann, I. Alkatout & M.K. Bohlmann. (2015) Operative Optionen bei Uterus myomatosusOperative options for uterine fibroids. Gynäkologische Endokrinologie 13:4, pages 219-225.
Crossref
Crossref
Michael K. Bohlmann, A. Hornemann, N. Sänger, A. Hackethal, K. von Horn, P.S. Wilkens & F. Hoellen. (2015) Medikamentöse MyomtherapieDrug therapy of uterine fibroids. Gynäkologische Endokrinologie 13:4, pages 226-231.
Crossref
Crossref
Friederike Hoellen & Michael K. Bohlmann. (2015) https://www.emjreviews.com/reproductive-health/article/new-concepts-in-the-therapeutic-management-of-myoma/. EMJ Reproductive Health, pages 87-94.
Crossref
Crossref
S. Di Tommaso, A. Tinelli, A. Malvasi & S. Massari. (2014) Missense mutations in exon 2 of the MED12 gene are involved in IGF-2 overexpression in uterine leiomyoma. Molecular Human Reproduction 20:10, pages 1009-1015.
Crossref
Crossref
Faustino R. Pérez-López, Lía Ornat, Iuliana Ceausu, Herman Depypere, C. Tamer Erel, Irene Lambrinoudaki, Karin Schenck-Gustafsson, Tommaso Simoncini, Florence Tremollieres & Margaret Rees. (2014) EMAS position statement: Management of uterine fibroids. Maturitas 79:1, pages 106-116.
Crossref
Crossref
Magdalena Maria Zalewski, Felix Zeppernick & Joseph Neulen. (2014) Erratum to: Update of Conservative Systemic Treatment of Uterine Fibroids. Current Obstetrics and Gynecology Reports 3:3, pages 196-200.
Crossref
Crossref
Magdalena Maria Zalewski & Joseph Neulen. (2014) Update of Conservative Systemic Treatment of Uterine Fibroids. Current Obstetrics and Gynecology Reports 3:3, pages 191-195.
Crossref
Crossref
Matthias D’Hondt, Maria Fedorova, Chien-Yu Peng, Bert Gevaert, Lien Taevernier, Ralf Hoffmann & Bart De Spiegeleer. (2014) Dry heat forced degradation of buserelin peptide: Kinetics and degradant profiling. International Journal of Pharmaceutics 467:1-2, pages 48-59.
Crossref
Crossref